Is Impact BioMedical Inc. (IBO) a Buy, Sell, or Hold?
AMEX : IBO
Impact BioMedical Inc.
$0.4303 USD
-$0.01 (-2.43%)
- Volume
- 7.8K
- Average Volume
- 61.97K
- Market Capitalization
- $5.38M
- P/E Ratio
- -0.34
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.83
- Year Low
- $0.37
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.22
Company Overview
AMEX
Frank D. Heuszel
Biotechnology
Healthcare
IBO
2
US
USD
Liquidity Metrics
0.00
0.22
0.19
0.01
0.00
Sales & Valuation
$32000
137.92
4.05
-3.22
-0.02
Profitability
-$0.38
-$11.84M
-32969.23%
-39630.77%
-2674.57%
-75.25%
P/E Metrics
-0.34
0.01
0.01
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-5.78
3/9
-$1.31M
$17.09M
$2.38M
-$14.94M
Key Metrics (TTM)
$5.66M
145.16
-0.41
0.22
-2674.57%
-24.85%
-26.25%
-29.43%
1705 days
Company Executives
| Name | Title |
|---|---|
| Mark J. Suseck | Chief Operating Officer |
| Todd D. Macko | Chief Financial Officer, Secretary & Treasurer |
| Frank D. Heuszel | Chairman & Chief Executive Officer |
Poll Results
No votes yet today — be the first to share your view!
About Impact BioMedical Inc. (AMEX:IBO) Stock
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimi ... crobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Frequently Asked Questions
-
What is the current Impact BioMedical Inc. (IBO) stock price?
-
Impact BioMedical Inc.(AMEX:IBO) stock price is $0.4303 in the last trading session. During the trading session, IBO stock reached the peak price of $0.83 while $0.37 was the lowest point it dropped to. The percentage change in IBO stock occurred in the recent session was --2.43% while the dollar amount for the price change in IBO stock was -$0.01.
-
IBO's industry and sector of operation?
-
The AMEX listed IBO is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IBO?
-
Mark J. Suseck | Chief Operating Officer
Todd D. Macko | Chief Financial Officer, Secretary & Treasurer
Frank D. Heuszel | Chairman & Chief Executive Officer
|
| -
How many employees does IBO have?
-
Number of IBO employees currently stands at 2. IBO operates from 1400 Broadfield Blvd., Houston, TX 77084, US.
-
Link for IBO official website?
-
Official Website of IBO is: https://www.impactbiomedinc.com
-
How do I contact IBO?
-
IBO could be contacted at phone #585-325-3610 and can also be accessed through its website. IBO operates from 1400 Broadfield Blvd., Houston, TX 77084, US.
-
How many shares of IBO are traded daily?
-
The average number of IBO shares traded daily for last 3 months was 61.97K.
-
What is the market cap of IBO currently?
-
The market value of IBO currently stands at $5.38M with its latest stock price at $0.4303